A case of preventable pulmonary tuberculosis in a Greenlandic, heavily immune suppressed patient

Immune modulating therapy, such as tumour necrosis factor (TNF)-alpha inhibitors, is becoming increasingly more widespread in the treatment of many autoimmune diseases. One of the well-documented side effects of TNF-alpha inhibitors is an increased risk of reactivating latent tuberculosis infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Anne-Sophie H., Johansen, Isik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920416/
https://www.ncbi.nlm.nih.gov/pubmed/26057468
http://dx.doi.org/10.1016/j.rmedc.2011.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920416/
https://www.ncbi.nlm.nih.gov/pubmed/26057468
http://dx.doi.org/10.1016/j.rmedc.2011.08.006

Ejemplares similares